Company Overview
About Hims & Hers Health
Hims & Hers Health is a telehealth and wellness platform offering personalized treatment plans and prescription medications for conditions including hair loss, erectile dysfunction, weight management, skincare, and mental health. Founded in 2017 and headquartered in San Francisco, Hims & Hers went public via SPAC merger in January 2021 and has grown into a $1B+ revenue publicly traded health company. The platform connects patients with licensed providers asynchronously and ships prescription treatments directly to homes, eliminating the friction of in-person doctor visits for lifestyle health conditions.
Business Model & Competitive Advantage
The company generated $872 million in revenue in 2024, growing over 40% year-over-year, driven significantly by its GLP-1 weight loss program which launched prescriptions for compounded semaglutide as Ozempic and Wegovy supply shortages created massive demand. Hims & Hers enrolled hundreds of thousands of weight loss subscribers in 2024, fundamentally changing its revenue mix and growth trajectory. The company serves over 2 million subscribers across its product lines.
Competitive Landscape 2025–2026
In 2025, Hims & Hers faces regulatory uncertainty around compounded GLP-1 medications as the FDA has moved to restrict compounding once brand-name shortages are resolved. The company has been diversifying its weight management portfolio and investing in its broader personalized health platform. Hims & Hers continues to expand its mental health (therapy, psychiatry) and women's health offerings while navigating the complex regulatory landscape of telehealth prescribing. Revenue is projected at $1.2B+ in 2025 as the company deepens patient relationships beyond single-condition treatments.
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
Hims & Hers Health is an emerging player bringing innovative solutions to the Healthcare market.
Growth Stage
Hims & Hers Health has achieved $872M in revenue, demonstrating strong product-market fit.
Massive User Base
Trusted by 2M worldwide, demonstrating broad market appeal and proven reliability.
Frequently Asked Questions
Not So Random Others
AbbVie
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Sp
Yoneda Labs
Yoneda Labs is a San Francisco-based AI company applying foundation models to automate chemical reaction optimization for drug discovery and pharmaceutical process development — providing chemists wit
YouShift
YouShift is a United States-based AI healthcare workforce management platform — building the operating system for healthcare staffing starting with AI-powered scheduling agents that replace the comple
Decoda Health
Decoda Health is a San Francisco-based AI healthcare administration platform — backed by Y Combinator (S23) with $4.5 million raised from YC, Amino Capital, Bossa Nova Ventures, Cadenza Ventures, Grap
Uncommon Therapeutics
Uncommon Therapeutics is a biotech company founded by Noah Auerhahn — directly inspired by his daughter's diagnosis with Rett Syndrome, a severe genetic neurological disease affecting approximately 1
Fortuna Health
Fortuna Health is a New York City-based healthcare technology company — backed by Y Combinator with $22 million in total funding including an $18 million Series A in July 2025 led by Andreessen Horowi
Compare Hims & Hers Health with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Hims & Hers Health? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Hims & Hers Health Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Hims & Hers Health vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →